Latest Medical therapy Stories
A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina.
Physicians are struggling to translate clinical research into everyday practice.
Despite guideline-based recommendations that underscore the importance of optimal medical therapy (OMT) for patients with stable coronary heart disease undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), data from a cardiovascular registry indicate that less than half of these patients are receiving OMT before PCI and approximately one-third are not receiving OMT at discharge following PCI,...
Cook Medical has completed enrollment in the first international clinical trial of a new drug-eluting stent designed to treat arterial blockages outside the coronary arteries.
Micrus Endovascular has announced that the Vitesse intracranial stent study for ischemic therapy clinical trial application has received conditional approved from the FDA.